INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION

By R. Spaide, K. Laud, H. Fine, J. Klancnik, Catherine B. Meyerle, L. Yannuzzi, J. Sorenson, J. Slakter, Y. Fisher, M. Cooney. Retina, 2006

657 citations recorded by the source corpus.

Subfields: Epidemiology, Ophthalmology

View Paper: https://www.semanticscholar.org/paper/350c66411645de38898afd8b4d1aa60a4a2c5272

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Ophthalmology

1. K. Eng
2. P. Kertes

Citations in the corpus

• Ranibizumab in neovascular age-related macular degeneration (2006, positive): “Another short-term, retrospective study of 266 eyes of 266 patients receiving monthly intravitreal bevacizumab for neovascular AMD found an improvement in mean visual acuity from 20/184 to 20/109 at 3 months (Spaide et al 2006).”